Stockscreener 앱 받기
9.89
0.40%
-0.04
시간 외 거래:
9.89
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals Drives PEDMARK Sales as Q1 Revenue Hits Peak - HarianBasis.co
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter - Yahoo Finance
H.C. Wainwright raises Fennec Pharmaceuticals stock price target on growing adoption By Investing.com - Investing.com Australia
Fennec Showcases New PEDMARK Data at ASCO 2026 - TipRanks
New PEDMARK studies at 2026 ASCO showcased by Fennec (NASDAQ: FENC) - Stock Titan
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $15 - Moomoo
H.C. Wainwright raises Fennec Pharmaceuticals stock price target on growing adoption - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting - Moomoo
H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Raises Target Price to $16 - Moomoo
Fennec Pharmaceuticals Announced New Research Supporting Integration and Use of PEDMARK at 2026 ASCO Annual Meeting - Moomoo
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting - The Manila Times
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of Pedmark - marketscreener.com
New cancer studies test PEDMARK to protect patients’ hearing - Stock Titan
(FENC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Fennec Pharmaceuticals Grants Inducement Stock Options to New Employees Under Nasdaq Rule and Highlights PEDMARK®/PEDMARQSI® Commercialization Progress 1 - Minichart
(FRX) Strategic Market Analysis (FRX:CA) - Stock Traders Daily
Fennec (NASDAQ: FENC) issues 50,000 inducement stock options to new hires - Stock Titan
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Fennec Pharmaceuticals Inc.Common Stock (NQ: FENC - FinancialContent
Fennec Pharmaceuticals : Corporate Presentation May 2026 - marketscreener.com
Three new Fennec hires get options on 50,000 shares at $9.75 - Stock Titan
Fennec Pharmaceuticals Inc Company Profile & Introduction - Moomoo
Fennec Pharmaceuticals(FENC) Stock Options Chain | Quotes & News - Moomoo
Fennec Pharmaceuticals (FENC) Stock Forum and Discussion - Moomoo
[SCHEDULE 13G/A] FENNEC PHARMACEUTICALS INC. Amended Passive Investment Disclosure - Stock Titan
Piper Sandler Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Fennec Pharmaceuticals (NASDAQ:FENC) Is In A Strong Position To Grow Its Business - Moomoo
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2026 Earnings Call Transcript - Insider Monkey
Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Fennec Pharmaceuticals (NASDAQ: FENC) turns Q1 profit as PEDMARK sales climb - Stock Titan
Rosalind group files Schedule 13G/A reporting stakes in Fennec (FENC) - Stock Titan
Adherex Technologies Q1 Earnings Call Highlights - TradingView
Earnings call transcript: Fennec Pharmaceuticals Q1 2026 earnings beat expectations By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals Crushes Q1 2026 Profit Estimates by 200.0% - AlphaStreet
Earnings call transcript: Fennec Pharmaceuticals Q1 2026 earnings beat expectations - Investing.com
Fennec Pharmaceuticals announces first quarter earnings and strategic initiatives - Traders Union
Fennec Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Fennec Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Fennec Pharmaceuticals Shares Rise After Earnings and Revenue Beat Forecasts (FENC) - Yahoo Finance
Fennec Pharmaceuticals up 12.6% in U.S. Pre-Market on Q1 Earnings as Pedmark Sales Jump 73% - marketscreener.com
Fennec Pharmaceuticals (NASDAQ:FENC) Q1 Beat Overshadowed by Surging Costs - ChartMill
Fennec Pharmaceuticals stock rises 3% on beating EPS, revenue estimates By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals stock rises 3% on beating EPS, revenue estimates - Investing.com India
FENNEC PHARMACEUTICALS ($FENC) Releases Q1 2026 Earnings - Quiver Quantitative
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand - TradingView
Fennec Pharma Achieved First Quarter 2026 Total Net Revenues of US$15.1 Million, Up 73% Year Over Year - marketscreener.com
Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ... By GuruFocus - Investing.com Canada
Fennec Pharmaceuticals (FENC) director exercises 14,344 options and sells shares for tax - Stock Titan
Fennec Pharmaceuticals Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
[144] FENNEC PHARMACEUTICALS INC. SEC Filing - Stock Titan
MSN Money - MSN
TradingKey - TradingKey
Number of shareholders of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
0.98%
0.12%
자본화:
|
볼륨(24시간):